{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:39:09Z","timestamp":1774690749416,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Defense Advanced Research Projects Agency (DARPA)","award":["DAMD17-03-2-0042"],"award-info":[{"award-number":["DAMD17-03-2-0042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ijantimicag.2011.03.003","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T08:48:34Z","timestamp":1304930914000},"page":"60-64","source":"Crossref","is-referenced-by-count":16,"title":["Post-exposure therapy of inhalational anthrax in the common marmoset"],"prefix":"10.1016","volume":"38","author":[{"given":"Michelle","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.H.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0005","unstructured":"US Centers for Disease Control and Prevention (CDC). Emergency preparedness and response. Bioterrorism agents\/diseases, by category. http:\/\/emergency.cdc.gov\/agent\/agentlist-category.asp [accessed 5 February 2010]."},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0010","unstructured":"Food and Drug Administration; HHS. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Regist 2002;67:37988\u201398."},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.micpath.2004.10.007","article-title":"Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain","volume":"38","author":"Flick-Smith","year":"2005","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","article-title":"Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin","volume":"67","author":"Varughese","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0035","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0040","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0045","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0264-410X(01)00461-3","article-title":"Anthrax vaccine efficacy in golden Syrian hamsters","volume":"20","author":"Fellows","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0050","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0060","first-page":"125","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in rhesus monkeys","volume":"87","author":"Ivins","year":"1996","journal-title":"Salisbury Med Bull"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0070","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/dkh276","article-title":"Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones","volume":"54","author":"Steward","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0080","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/AAC.01050-06","article-title":"Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model","volume":"51","author":"Heine","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0085","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/IAI.70.11.6231-6241.2002","article-title":"Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs","volume":"70","author":"Altboum","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","volume":"54","author":"Henderson","year":"1956","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax","volume":"167","author":"Friedlander","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0100","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax","volume":"103","author":"Vietri","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/596063","article-title":"A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics","volume":"199","author":"Vietri","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3201\/eid0802.01-0521","article-title":"Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax","volume":"8","author":"Bell","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2613.2008.00581.x","article-title":"Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus)","volume":"89","author":"Lever","year":"2008","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0120","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/infdis\/166.5.1184","article-title":"Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys","volume":"166","author":"Kelly","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S0022172400041851","article-title":"A mobile form of the Henderson apparatus","volume":"67","author":"Druett","year":"1969","journal-title":"J Hyg (Lond)"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2011.03.003_bib0130","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/jac\/43.suppl_1.49","article-title":"Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500mg tablet compared with 500mg\/10mL or 500mg\/5mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension","volume":"43","author":"Shah","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0135","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1128\/AAC.00390-10","article-title":"Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus)","volume":"54","author":"Nelson","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0140","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1128\/AAC.00090-06","article-title":"Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model","volume":"50","author":"Kao","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0145","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.LAB.0000080599.43791.01","article-title":"Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis)","volume":"83","author":"Vasconcelos","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.ijantimicag.2011.03.003_bib0150","first-page":"691","article-title":"Pathology of experimental inhalation anthrax in the rhesus monkey","volume":"73","author":"Fritz","year":"1995","journal-title":"Lab Invest"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911001464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911001464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:37:24Z","timestamp":1592527044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911001464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0924857911001464"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.03.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}